108 related articles for article (PubMed ID: 23343695)
1. Temporal trends in genital warts among individuals covered by the public prescription drug insurance plan in the province of Quebec, Canada, from 1998 to 2007.
Steben M; Ouhoummane N; Rodier C; Brassard P
J Low Genit Tract Dis; 2013 Apr; 17(2):147-53. PubMed ID: 23343695
[TBL] [Abstract][Full Text] [Related]
2. The early impact of human papillomavirus vaccination on anogenital warts in Québec, Canada.
Steben M; Ouhoummane N; Rodier C; Sinyavskaya L; Brassard P
J Med Virol; 2018 Mar; 90(3):592-598. PubMed ID: 28980715
[TBL] [Abstract][Full Text] [Related]
3. Significant Reduction in the Incidence of Genital Warts in Young Men 5 Years into the Danish Human Papillomavirus Vaccination Program for Girls and Women.
Bollerup S; Baldur-Felskov B; Blomberg M; Baandrup L; Dehlendorff C; Kjaer SK
Sex Transm Dis; 2016 Apr; 43(4):238-42. PubMed ID: 26967300
[TBL] [Abstract][Full Text] [Related]
4. Twenty-year trends in the incidence and prevalence of diagnosed anogenital warts in Canada.
Kliewer EV; Demers AA; Elliott L; Lotocki R; Butler JR; Brisson M
Sex Transm Dis; 2009 Jun; 36(6):380-6. PubMed ID: 19556932
[TBL] [Abstract][Full Text] [Related]
5. Assessing incidence and economic burden of genital warts with data from a US commercially insured population.
Hoy T; Singhal PK; Willey VJ; Insinga RP
Curr Med Res Opin; 2009 Oct; 25(10):2343-51. PubMed ID: 19650749
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the Early Benefit of Quadrivalent HPV Vaccine on Genital Warts in Belgium: A Cohort Study.
Dominiak-Felden G; Gobbo C; Simondon F
PLoS One; 2015; 10(7):e0132404. PubMed ID: 26147096
[TBL] [Abstract][Full Text] [Related]
7. Significant decrease in the incidence of genital warts in young Danish women after implementation of a national human papillomavirus vaccination program.
Baandrup L; Blomberg M; Dehlendorff C; Sand C; Andersen KK; Kjaer SK
Sex Transm Dis; 2013 Feb; 40(2):130-5. PubMed ID: 23324976
[TBL] [Abstract][Full Text] [Related]
8. Evidence for effectiveness of a national HPV vaccination programme: national prescription data from New Zealand.
Wilson N; Morgan J; Baker MG
Sex Transm Infect; 2014 Mar; 90(2):103. PubMed ID: 24526666
[No Abstract] [Full Text] [Related]
9. Rates and predictors of genital warts burden in the Czech population.
Petráš M; Adámková V
Int J Infect Dis; 2015 Jun; 35():29-33. PubMed ID: 25869075
[TBL] [Abstract][Full Text] [Related]
10. Incidence of genital warts in adolescents and young adults in an integrated health care delivery system in the United States before human papillomavirus vaccine recommendations.
Camenga DR; Dunne EF; Desai MM; Gee J; Markowitz LE; Desiliva A; Klein NP
Sex Transm Dis; 2013 Jul; 40(7):534-8. PubMed ID: 23965766
[TBL] [Abstract][Full Text] [Related]
11. Incidence and human papillomavirus (HPV) type distribution of genital warts in a multinational cohort of men: the HPV in men study.
Anic GM; Lee JH; Stockwell H; Rollison DE; Wu Y; Papenfuss MR; Villa LL; Lazcano-Ponce E; Gage C; Silva RJ; Baggio ML; Quiterio M; Salmerón J; Abrahamsen M; Giuliano AR
J Infect Dis; 2011 Dec; 204(12):1886-92. PubMed ID: 22013227
[TBL] [Abstract][Full Text] [Related]
12. Patterns of discontinuation of atypical antipsychotics in the province of Québec: A retrospective prescription claims database analysis.
Moisan J; Grégoire JP
Clin Ther; 2010; 32 Suppl 1():S21-31. PubMed ID: 20152549
[TBL] [Abstract][Full Text] [Related]
13. Impact of quadrivalent human papillomavirus vaccine in women at increased risk of genital warts burden: Population-based cross-sectional survey of Czech women aged 16 to 40 years.
Petráš M; Adámková V
Vaccine; 2015 Nov; 33(46):6264-7. PubMed ID: 26431981
[TBL] [Abstract][Full Text] [Related]
14. Strongly decreased risk of genital warts after vaccination against human papillomavirus: nationwide follow-up of vaccinated and unvaccinated girls in Denmark.
Blomberg M; Dehlendorff C; Munk C; Kjaer SK
Clin Infect Dis; 2013 Oct; 57(7):929-34. PubMed ID: 23804192
[TBL] [Abstract][Full Text] [Related]
15. Recurrence of Human Papillomavirus External Genital Wart Infection Among High-Risk Adults in Montréal, Canada.
Thomas R; Steben M; Greenwald Z; Stutz M; Rodier C; DeAngelis F; Rampakakis E
Sex Transm Dis; 2017 Nov; 44(11):700-706. PubMed ID: 28876315
[TBL] [Abstract][Full Text] [Related]
16. Ongoing decline in genital warts among young heterosexuals 7 years after the Australian human papillomavirus (HPV) vaccination programme.
Chow EP; Read TR; Wigan R; Donovan B; Chen MY; Bradshaw CS; Fairley CK
Sex Transm Infect; 2015 May; 91(3):214-9. PubMed ID: 25305210
[TBL] [Abstract][Full Text] [Related]
17. [A model-based comparison of cost effectiveness of imiquimod versus podophyllotoxin for the treatment of external anogenital warts in France].
Lafuma A; Monsonego J; Moyal-Barracco M; Pribil C
Ann Dermatol Venereol; 2003; 130(8-9 Pt 1):731-6. PubMed ID: 14576602
[TBL] [Abstract][Full Text] [Related]
18. Dose-Related Differences in Effectiveness of Human Papillomavirus Vaccination Against Genital Warts: A Nationwide Study of 550,000 Young Girls.
Blomberg M; Dehlendorff C; Sand C; Kjaer SK
Clin Infect Dis; 2015 Sep; 61(5):676-82. PubMed ID: 25944340
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of imiquimod versus podophyllotoxin in the treatment of anogenital warts.
Komericki P; Akkilic-Materna M; Strimitzer T; Aberer W
Sex Transm Dis; 2011 Mar; 38(3):216-8. PubMed ID: 20938374
[TBL] [Abstract][Full Text] [Related]
20. Rate and predictors of new genital warts claims and genital warts-related healthcare utilization among privately insured patients in the United States.
Koshiol JE; Laurent SA; Pimenta JM
Sex Transm Dis; 2004 Dec; 31(12):748-52. PubMed ID: 15608590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
